Starting a Business in CRISPR
By Stephanie Vine
May 2, 2025
From a love of history books to a love of CRISPR, Monika Paule tells us the story of her career and the origins of Caszyme.
8 min read
False
Advertisement
Sitting Down With
Kite, CAR Ts, and Access for Patients
By Stephanie Vine
April 25, 2025
Depending on the country, only about two in 10 eligible patients, on average, receive CAR T-cell therapy. We sat down with Kite’s Cindy Perettie to talk about access to CAR Ts.
9 min read
Going From Benchtop Chemist to CEO: Part 2
By Stephanie Vine
April 21, 2025
In Part 1 of our interview with Simon Tasker, he explained how he joined Colorcon as a bench chemist – and never left...
5 min read
From Benchtop Chemist to CEO
By Stephanie Vine
April 17, 2025
After his postdoc, Simon Tasker joined Colorcon as a bench chemist – and never left. Today, he’s the company’s CEO. Here’s how his career unfolded as he grew within the company he now leads.
5 min read
Rewards in the Real World: Sitting Down With Igor Fisch
April 16, 2025
Discussing the development of trends, treatments, and talent in gene therapy with NewBiologix CEO Igor Fisch.
4 min read
The Blood Cancer Success Story: Part 2
By Stephanie Vine
April 15, 2025
We interview Lore Gruenbaum about The Leukemia & Lymphoma Society, advances in blood cancers, and how the field has seen many therapeutic firsts for the industry.
6 min read
The Blood Cancer Success Story: Part 1
By Stephanie Vine
April 9, 2025
Lore Gruenbaum tells us about her career spanning big pharma, biotech and now The Leukemia & Lymphoma Society; because there are some goals you can only accomplish in a not-for-profit environment.
7 min read
Sitting Down With... Moncef Slaoui
March 3, 2025
From the GSK boardroom to the White House, and now the board of Abzena, the career path of Moncef Slaoui has resulted in billions of doses of lifesaving vaccines. Here he shares his story.
5 min read
Irish Horizons: Sitting Down With BMS’ Karen Costello
February 17, 2025
Following a spell at Bristol Myers Squibb’s New Jersey facility, General Manager for the Irish commercial affiliate, Karen Costello, returns to her native country to help get medicines to Irish patients faster.
4 min read
Maintaining Momentum
February 6, 2025
Being part of the cell and gene therapy field is an incredible privilege, according to Frank Mathias, CEO, Oxford Biomedica.
4 min read
